At AstraZeneca, we're not afraid to do things differently. We're resetting expectations of what a bio-pharmaceutical company can be. This means we're opening new ways to work, ground-breaking and cutting-edge methods and bringing unexpected teams together
AstraZeneca is organised around two core business units, BioPharmaceuticals (BBU) and Oncology. The BBU focuses on development and commercialisation of AstraZeneca’s Respiratory, Cardiovascular, Metabolic, Renal and Infectious Disease therapeutic areas.
Global Insights, Analytics & Commercial Excellence (GIACE) is a strategic function, critical for enabling success in the growth of the BBU business. Our ambition is to build an industry-leading organisation, empowering our Commercial teams through the generation of compelling evidence and insights, while ensuring they have the tools and skills to deliver impactful launches that change the practice of medicine for the benefit of patients. Within GIACE, the Insights & Analytics function is organised across three teams and supports both the US and Global organisation.
The aim of the Insights & Analytics Center of Excellence is to establish industry-leading capabilities across the core areas of analytics, forecasting, reporting, business planning, and insight capabilities. It will leverage, reapply, and advance best practices in capabilities and operations from Global and US more broadly across geographies. In the area of advanced analytics, the ambition is to accelerate the development and application of advanced analytic methodologies such as machine learning and artificial intelligence to solve business problems. The CoE also aims to scale and deploy these capabilities in a highly efficient manner so that continuous innovation can be pursued.
The Insight Teams and the CoE partner to drive portfolio and brand strategy and performance. Together we strive to uncover deep customer insights in order to drive improved decision-making and business impact. We are looking for leaders who have the passion to drive business results and bring innovation to what we do for greater impact.
The Forecasting Leader is a critical business, producing forecasts and collaborating with the team on how to manage risks and opportunities for the business. As a Forecast Leader, you will have responsibility for a brand/brands and play an integral role in understanding performance, setting expectations for performance, and guiding brand strategy. You will be responsible for implementing and ensuring consistent application of best practices across the organisation drawing from inside and outside the industry, leading to objective forecasts supported by insight & analytics. You will partner with the Forecast Lead, Senior Director to help develop and implement new capabilities and improvements and assist in training across the Forecasting team.
You will develop product-specific short-term and long-term forecasts models and maintain up-to-date forecast models, reflecting current data, information, assumptions; lead the forecasting and business planning processes and all associated work streams (sales bridges, ad hocs supporting Finance, etc.); Identify key business issues that impact short-term and long-range product and market forecasts; clearly and pro-actively surface these issues, incorporate the results of primary research into the forecast model(s) to reflect anticipated risks and opportunities on sales outlook, and define forecasting processes and build capabilities in forecasting for inline and late stage assets. In addition, you will have responsibility to develop forecasts for your focused therapeutic area using patient flow forecast models, patient based forecast models, and statistical trending and ensure alignment on forecast assumptions and other critical analytical assessments with business partners.
This role is reserved for someone who has deep forecasting and quantitative technical skills combined with outstanding communication skills. As such, those who will qualify for this position are both technically sound and have the ability to be a proactive internal consultant, adding value to AstraZeneca's commercial organisation beyond their analytical prowess through their understanding of secondary data, industry knowledge, and track record of innovative and impactful decision support.